Organogenesis Holdings Inc (ORGO) posted 6% sequential revenue growth and sharp expense reductions while navigating a 70% revenue decline and an extended Amnuvix PDUFA timeline.
Motley Fool Press Release.
This is the newest page. Registered accounts read further back.